Research & Development: Page 41
-
An Industry Call to Action: A Convergence Model Driven By Real World Intelligence
As payers escalate measures to contain costs, providers adjust to new models such as the Affordable Care Act, and patients assume more financial responsibilities for their care, manufacturers are being forced to generate more complex and comprehensive bodies of real world evidence (RWE) about dru...
By Ramita Tandon • June 1, 2016 -
Industry Trends for Life-Science Talent
What workforce trends can the life-sciences industry expect to see through the end of 2016? Developments that were set in motion in the past two years will continue to disrupt the market, broadening the life-sciences workforce spectrum, and change how top talent wants to be engaged. Workforce En...
By Kevin D. Duffy • June 1, 2016 -
Trendline
Oncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
How Uber's Tech Model Is Driving Improvements in Clinical Trial Payments
In Tom Goodwin’s oft-quoted article in TechCrunch last year, he says: “Uber, the world’s largest taxi company, owns no vehicles. Facebook, the world’s most popular media owner, creates no content. Alibaba, the most valuable retailer, has no inventory. And Airbnb, the world’s largest accommodation...
By April Mulroney • June 1, 2016 -
Biomarkers Supporting Clinical Trials: A Quality Driven & Integrated Approach to Advancing Drug Development
The pharmaceutical industry faces major challenges; patent expiry, generic competition, weak pipelines, spiralling R&D costs, high attrition rates, and falling drug approval rates. In response, the drug development landscape is set for major changes in the coming five to 10 years. Most pharma...
By Paul Travis • June 1, 2016 -
Assessing SaaS Vendors in Clinical Research: Best Practices to Ensure Compliance
As the adoption of digital technology such as cloud-based data capture and management into clinical research has increased, the scope and complexity of conducting – and, therefore, preparing for – regulatory audits have become more complex. This trend, coupled with the expansion of trials across ...
By Anu Virkar • June 1, 2016 -
Cancer Immunotherapy and Other Advanced Therapies: Opportunity and Challenges Combine to Bring Tomorrow's Treatments to Patients
The immunotherapy field holds great promise. Many of these therapies represent a “breakthrough“ in cancer treatment, as well as other diseases and disorders, and may revolutionize the way we treat various illnesses. As an example, immunotherapy treatments for oncology can be delivered using a va...
By Etienne Drouet • June 1, 2016 -
Healthcare Needs A Hero
Hero is a big word. The image it brings to mind is someone who saves the day or who stands up for what is right. The bar is set pretty high for what makes a hero today. The pharma industry is full of heroes. They don’t walk around wearing capes or rappel down the face of a skyscraper to take out ...
By Patrick Lindsay • June 1, 2016 -
Complexity and Specialization: An Inevitable Dance
For decades, general practitioners successfully managed the healthcare needs of entire families. From treating the common cold to addressing urgent injuries, from delivering babies to providing geriatric care, the family doctor was there to see us through all walks and phases of life. Today, alth...
By Donal A. Deieso • June 1, 2016 -
Innovator's Corner
Transforming Diabetes Treatment Paul Laikind, Ph.D., President and CEO of ViaCyte, talks about the company’s research on a stem-cell derived therapy for diabetes. About 29.1 million people — about 1 out of every 11 people — have diabetes. About 5%, or about 1.25 million people, have type 1 diabet...
By Paul Laikind • May 1, 2016 -
HIV Vaccine Update
In 2015, Bill Gates caused a media stir by expressing optimism that a vaccine and a cure for HIV will become a reality within the next 15 years. The National Institutes of Health and other researchers have made progress in understanding how HIV antibodies develop and the potential of a vaccine to...
By Denise Myshko • May 1, 2016 -
HBA Rising Stars: Healthcare Vision 2020
PharmaVOICE has exclusive access to nearly 100 women leaders, who are providing their take on the trends that are expected to shape the healthcare industry in the next four years. Identified by their companies as HBA Rising Stars and Luminaries, these industry executives talk about everything fro...
By PharmaVoice Team • May 1, 2016 -
What's New
TransCelerate BioPharma Introduces New Subsidiary Trending now: Six biopharmaceutical companies launch subsidiary with first initiative-toxicology data sharing. TransCelerate BioPharma has launched BioCelerate, a new subsidiary that aims to improve efficiencies in preclinical research. The six in...
By PharmaVoice Team • April 1, 2016 -
Pharma Trax
Physicians Value Digital Sales Aids Trending now: Survey of physicians reveals they want stronger and more custom content from sales aids. While most pharmaceutical representatives today are armed with tablet devices and direct sales aids (DSAs), many are not using them effectively during physici...
By PharmaVoice Team • April 1, 2016 -
The Calendar
Coming Attractions DIA 2016 — a Gathering of Global Proportions — is the largest global interdisciplinary event that brings together 7,000-plus key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations in Phila...
By PharmaVoice Team • April 1, 2016 -
Innovative Science and Products
Innovation in the life-sciences industry is widely diverse. Products range from Google’s Lift Lab’s “super spoon" to help people with essential tremors and Parkinson’s disease to eat without spilling — in clinical trials, the Liftware spoons reduced shaking of the spoon bowl by an average of 76% ...
By PharmaVoice Team • April 1, 2016 -
Innovator's Corner
A New Targeted Cancer Treatment Dr. Joshua Allen, VP for Research and Development at Oncoceutics, talks about his company’s approach to target cancer. Targeted therapies are the focus of many cancer drug development programs. They are a cornerstone of precision medicine, which uses information a...
By Dr Joshua Allen • March 1, 2016 -
Pharma Trax
Protocol Amendments Come at a High Cost Trending now: New analysis provides insight into the impact of clinical trial amendments and how to anticipate and manage them. Research sponsors implement at least one substantial global amendment for almost 60% of all clinical trial protocols, substantia...
By PharmaVoice Team • March 1, 2016 -
Preparing for an Outcomes-based Sales Model
According to a recent report by Accenture, three factors — reimbursement models, changing buyer profiles, and digital capabilities — are changing the pharmaceutical and healthcare industries and directly impacting the traditional pharmaceutical sales rep model. However, these factors also represe...
By Robin Robinson • March 1, 2016 -
The Microbiome: A New Research Tool
Our bodies are home to trillions of microbes, including bacteria, fungi, and viruses. These microbes are essential; they help digest food, produce certain vitamins, and regulate the immune system. Until recently, little was known about these microbes, but advances in DNA sequencing are making it ...
By Denise Myshko • March 1, 2016 -
Pharma Trax
Biopharma Sales Operations Stabilizing Trending now: Growth in sales operations spending driven by changing biopharma challenges and priorities. The biopharmaceutical sales operations rollercoaster ride appears to have leveled off, according to TGaS Advisors. A recent TGaS Commercial Operations L...
By PharmaVoice Team • Feb. 1, 2016 -
The Calendar
Coming Attractions The Pennsylvania BIO 2016 Annual Dinner and Awards Celebration is the premier event of the season for the life-sciences industry in Pennsylvania. On March 10th, more than 1,000 attendees will convene for this can’t-miss event Thursday, March 10, 2016, at the PA Convention Cente...
By PharmaVoice Team • Feb. 1, 2016 -
SHOWCASE FEATURE: Outsourcing: Strategic Partnerships
After years of paying lip service to the need for truly strategic partnerships between sponsors and CROs as a way to increase efficiencies, improve timelines to market, and reduce costs, the time may be right for both parties. According to Nice Insights’ most recent survey 2016 CRO Buying Trends,...
By Taren Grom • Feb. 1, 2016 -
Countdown to Launch: Strategies For Efficiency, Acceleration and Performance
As new drug launches proliferate in the increasingly complex specialty therapeutic space, biopharma is finding that success is often pre-determined by actions that take place very early in the development and commercialization cycle. In fact, the earlier companies start thinking through their lau...
By Dean Giovanniello • Feb. 1, 2016 -
UpFront
Industry at Large Helping Kids with Asthma Medikidz and Meda Pharmaceuticals have launched Explain Asthma, a comic book series launched in conjunction with the American College of Asthma, Allergy, and Immunology (ACAAI). The series is designed to help families gain an accurate understanding of as...
By PharmaVoice Team • Jan. 1, 2016 -
Innovator's Corner
Modifying the Immune System for Those with Food Allergies DBV Technologies’ CEO and Co-founder Pierre-Henri Benhamou talks about his company’s development of a patch for peanut and other food allergies. The prevalence of food allergies appears to be on the rise. While there is no cure for food al...
By Pierre-Henri Benhamou • Jan. 1, 2016